Quantification of the sixth DNA base 5-hydroxymethylcytosine in colorectal cancer tissue and C-26 cell line

Bioanalysis

Volumn 5, Issue 7, 2013, Pages 839-845

  Zhang, Liang Tao ^a   Zhang, Li Jian ^a   Zhang, Jun Jie ^a   Ye, Xiao Xia ^a   Xie, Ai Mei ^a   Chen, Li Yu ^a   Kang, Jing X ^b   Cai, Chun ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; CYTOSINE;

ACCURACY; ADULT; AGED; ANIMAL CELL; ARTICLE; CALIBRATION; CANCER CELL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; VALIDITY;

CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMATOGRAPHY, LIQUID; COLORECTAL NEOPLASMS; CYTOSINE; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; TANDEM MASS SPECTROMETRY;

EID: 84875760285     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.28     Document Type: Article

References (25)

1. Jones PA, Baylin SB. The epigenomics of cancer. Cell 128(4), 683-692 (2007).
2. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 358(11), 1148-1159 (2008).
3. Penn NW, Suwalski R, O'Riley C, Bojanowski K, Yura R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 126(4), 781-790 (1972).
4. Kriaucionis, S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929), 929-930 (2009).
5. Tahiliani M, Koh KP, Shen Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929), 930-935 (2009).
6. Globisch D, Münzel M, Müller M et al. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS One 5(12), e15367 (2010).
7. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res. 38(19), e181 (2010).
8. Song C-X, Szulwach KE, Fu Y et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29(1), 68-72 (2011).
9. Ko M, Huang Y, Jankowska AM et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468(7325), 839-843 (2010).
10. Valinluck V, Tsai H-H, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32(14), 4100-4108 (2004).
11. Liutkeviciute Z, Lukinavicius G, Masevicius V, Daujotyte D, Klimasauskas S. Cytosine-5-methyltransferases add aldehydes to DNA. Nat. Chem. Biol. 5(6), 400-402 (2009).
12. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254(2), 317-330 (1988).
13. Zhang L, Zhang L, Zhou K et al. Simultaneous determination of global DNA methylation and hydroxymethylation levels by hydrophilic interaction liquid chromatography-tandem mass spectrometry. J. Biomol. Screen. 17(7), 877-884 (2012).
14. Rossella F, Polledri E, Bollati V, Baccarelli A, Fustinoni S. Development and validation of a gas chromatography/mass spectrometry method for the assessment of genomic DNA methylation. Rapid Commun. Mass Spectrom. 23(17), 2637-2646 (2009).
15. Hashimoto H, Zhang X, Cheng X. Excision of thymine and 5-hydroxymethyluracil by the MBD4 DNA glycosylase domain: structural basis and implications for active DNA demethylation. Nucleic Acids Res. 40(17), 8276-8284 (2012).
16. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry. Bioanalytical Method Validation. FDA, Rockville, MD, USA (2001)
17. Haffner MC, Chaux A, Meeker AK et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2(8), 627-637 (2011).
18. Jin SG, Jiang Y, Qiu R et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 71(24), 7360-7365 (2011).
19. Kraus TF, Globisch D, Wagner M et al. Low values of 5- hydroxymethylcytosine (5-hmC), the "sixth base," are associated with anaplasia in human brain tumors. Int. J. Cancer 131(7), 1577-1590 (2012).
20. Koh KP, Yabuuchi A, Rao S et al. TET1 and TET2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8(2), 200-213 (2011).
21. Hernandez-Blazquez FJ, Habib M, Dumollard J-M et al. Evaluation of global DNA hypomethylation in human colon cancer tissues by immunohistochemistry and image analysis. Gut 47(5), 689-693 (2000).
22. Zhang JJ, Zhang L, Zhou K et al. Analysis of global DNA methylation by hydrophilic interaction ultra high-pressure liquid chromatography tandem mass spectrometry. Anal. Biochem. 413(2), 164-170 (2011).
23. Chowdhury R, Yeoh KK, Tian YM et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12(5), 463-469 (2011).
24. Xu W, Yang H, Liu Y et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1), 17-30 (2011).
25. Gal-Yam EN, Saito Y, Egger G, Jones PA. Cancer epigenetics: modifications, screening, and therapy. Annu. Rev. Med. 59, 267-280 (2008).